Robert Tahara, MD
Vascular Surgery · Bradford, PANPI 1902859069
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (57.2%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Angiodynamics, Inc. accounts for 65.8% of it on its own, with 39 other manufacturers making up the rest. 2025 is the largest year on record at $10,440, 5.7 times the $1,824 reported in 2019. Among vascular surgery clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 357 payments — averaging $117.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$28K
- Boston Scientific$3K
- Bard Peripheral Vascular, Inc.$1K
- Medtronic$1K
- Philips North America LLC$1K
- Johnson & Johnson$903
- plus $7K from 34 others
Across 3 payments — averaging $33,333 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$100K
What the payments were for
- Consulting fees$3,0007%
- Speaking & faculty fees$2,2505%
- Food & beverage$12,66630%
- Education$600%
- Other$24,00057%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$26,661
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$769
- Venclose Maven Catheter$300
- GENERAL VASCULAR INTERVENTION$290
- Diamondback Peripheral$206
- Alto Abdominal Stent Graft System$177
- Abre$159
- Hemodialysis System$149
- Torus Stent Graft System$146
- ENDOCROSS Device$146
- Fluency Endovascular Stent Graft$141
- FLOWTRIEVER CATHETER, S$138
- CT THROMBECTOMY SYSTEM KIT$138
- Phi 100 Flex coil$134
- IGT D Service Syst$131
- VISTA BRITE TIP$124
- HawkOne$120
- (BR5) Peripheral IVUS$120
- IGT D Peripheral$116
- VIABAHN Endoprosthesis with Heparin Bioactive Surface$115
How this compares
$41,976 in reported general payments places this provider in the 90th percentile of 236 vascular surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 332 | $271,909 |
| EliquisApixaban | 196 | $126,516 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 20 | $5,085 |
| ClopidogrelClopidogrel Bisulfate | 135 | $1,668 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $903 | $271,909332 claims |
| PfizerEliquis | $206 | $126,516196 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 236 vascular surgery providers in Pennsylvania.
Other vascular surgery in Bradford
- Darren SchneiderPhiladelphia$569K
- Elizabeth GenovesePhiladelphia$343K
- Shang LohPhiladelphia$306K
- Paul FoleyDoylestown$241K
- Michel MakarounPittsburgh$143K
- Robert MeisnerLebanon$128K
- Vincent DigiovanniMedia$127K
- Efthymios AvgerinosPittsburgh$120K
- Meghan DermodyLancaster$103K
- Carleen ChoErie$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.